Highlights
- •Spinal cord syndrome is a common feature of progressive Multiple Sclerosis.
- •We described demyelinating progressive myelopathy not meeting any diagnostic criteria.
- •Current classification of inflammatory demyelinating diseases is still incomplete.
- •New variants for atypical presentations should be considered in future revisions.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Multiple Sclerosis and Related DisordersAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Idiopathic inflammatory-demyelinating diseases of the central nervous system.Neuroradiology. 2007; 49: 393-409
- Oral and intravenous steroids for multiple sclerosis relapse: a systematic review and meta-analysis.J. Neurol. 2017; 264: 1697-1704
- Prediction of disability progression in fingolimod-treated patients.J. Neurol. Sci. 2015; 358: 432-434
- Persistence to oral disease-modifying therapies in multiple sclerosis patients.J. Neurol. 2017; 264: 2325-2329
- Multiple sclerosis, solitary sclerosis or something else?.Mult. Scler. 2014; 20: 1819-1824
- Solitary sclerosis. progressive myelopathy from solitary demyelinating lesion.Neurology. 2012; 78: 540-544
- Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria.Lancet Neurol. 2018; 17: 162-173
Article info
Publication history
Published online: August 15, 2019
Accepted:
August 14,
2019
Received in revised form:
August 9,
2019
Received:
July 8,
2019
Identification
Copyright
© 2019 Elsevier B.V. All rights reserved.
